Connect with us

News

Women’s health innovations recognised in TIME’s Best Inventions 2025

Published

on

TIME Magazine has published its Best Inventions of 2025, spotlighting 300 innovations making the world a better place. Femtech World spoke to some of those addressing unmet needs in women’s health.

For 25 years, TIME’s Best Inventions issue has been highlighting the most impactful new products and ideas. 

This year, several femtech innovations made the list – from predictive pregnancy tools and safer postpartum care to hormone-free contraception and more accessible menstrual products.

Speaking to Femtech World, founders say this reflects a growing global recognition of the importance of technology and innovation for improving women’s experience of health and care worldwide.

“This recognition isn’t just about our company, it’s about what it represents for women’s health and women inventors,” says Sarah-Almaza Cox, co-founder of Joeyband, which made the Honourable Mentions list.

“Femtech has often been overlooked in the broader innovation landscape, yet it holds the power to change how care is delivered, experienced, and valued. For TIME to celebrate devices like Joeyband alongside global innovations signals a shift, one that honours the science, empathy, and leadership women bring to healthcare innovation.”

We take a closer look at the inventions that made the list and how they are helping to close the gender health gap.

HerBrain: “A breakthrough in pregnancy information”

HerBrain, developed by the Geometric Intelligence Lab at the University of California, Santa Barbara and recognised in TIME’s Health and Wellness category, is the first digital twin of the maternal brain.

Led by Professor Nina Miolane, who gave birth herself last year, the tool uses machine learning and brain imaging data from pregnant individuals to model how brain structures change throughout pregnancy and postpartum, allowing expectant mothers to track and anticipate weekly shifts in their brains. 

The app is currently in development and is expected to launch in 2027, with the aim of integrating the tool into popular pregnancy apps to give women a clearer picture of how their bodies and brains change during pregnancy.

“Our goal is not only to educate but also to advance understanding of maternal brain health, paving the way for innovations that could benefit all women,” the researchers said in a statement announcing the news.

Mirvie Encompass: “Predicting preeclampsia”

Femtech World award-winner Mirvie’s first-of-its-kind Encompass technology was named in the top Medical and Healthcare inventions category.

Encompass provides personalised predictions of the risk of preeclampsia early in pregnancy through a simple blood test. This allows women and their healthcare providers to take action earlier to support a healthy pregnancy and aims to address increasing preeclampsia rates. TIME highlighted a 10,000-patient study published earlier this year, in which Encompass correctly identified 91 per cent of women who would develop preterm preeclampsia. 

Maneesh Jain, CEO and co-founder of Mirvie, commented: “We are proud and honoured that Encompass is recognised as a TIME Best Invention of 2025. For 100 years, the reactive approach to identifying preeclampsia in pregnancy hasn’t changed – until now. “At Mirvie, we’ve invented tools that predict pregnancy complications – like preeclampsia – early enough for moms and their care teams to take preventive action. Innovations like Encompass are essential to delivering the next-generation pregnancy care that is needed to improve maternal health outcomes.” 

Miudella, Sebala Women’s Health: “A groundbreaking hormone-free IUD”

The first hormone-free copper IUD to obtain FDA approval in 40 years, Midudell by Sebala Women’s Health, also made TIME’s list. 

The device, which aims to improve women’s experience of contraception, was granted approval by the FDA in February 2025. Kelly Culwell, head of research and development at Sebala Women’s Health, explained that Miudella was designed to improve the insertion experience through a preloaded inserter with a rounded tapered tip and narrow insertion tube diameter.

The flexible nitinol frame and lower dose of copper were designed to decrease the side effects of using a copper IUD, including lower rates of expulsion and side effects of bleeding and pain.

“We are delighted that MIUDELLA was named to TIME’s Best Inventions of 2025 list,” Culwell told Femtech World.

“This recognition further supports our belief that the novel design of MIUDELLA will offer an innovative option for birth control for women nationwide.

“The response from healthcare providers, our current study investigators and women has been very positive since FDA approval. There is clearly an unmet need for additional non-hormonal contraceptive options in the US.”

Joeyband: “Uninterrupted skin-to-skin contact”

Making the Honourable Mentions list, Joeyband enables uninterrupted skin-to-skin contact between newborns and their caregivers in hospital settings such as operating rooms and NICUs. Created out of one mother’s experience, the device is now used in hospitals around the world to improve postpartum recovery and health outcomes.

“As a Canadian company, being honoured by TIME’s Best Inventions is deeply meaningful,”  says Cox.

“Joeyband was born from a moment of fear, but has transformed into a movement for safer, more connected beginnings for families everywhere. It started with a gap that Hayley Mullins (Inventor of Joeyband) recognised in how mothers and caregivers could safely practice skin-to-skin, and has grown into a device now used in hospitals and homes around the world. 

“For us, this recognition reinforces that meaningful innovation doesn’t always come from a lab; sometimes it starts in your living room, holding your newborn, dreaming of a better way.”

Egal Pads on a Roll: “Ultra accessible menstrual pads”

Designed to address poor access to menstrual products and make period care more convenient, Egal Pads’ ‘Pads on a Roll’ were also named in TIME’s Health and Wellness category. 

The concept was created by Tom Devlin, whose wife reported on women’s issues for the Boston Globe. By designing pads to resemble a toilet paper roll, which fit into standard dispensers, the aim was to normalise their presence while eliminating the costs associated with vending machines. According to TIME, the company now supplies more than 1,700 schools, libraries, and healthcare facilities. 

“We at Egal Pads are thrilled that ‘pads on a roll’ won as one of the best inventions in 2025,” said Penelope Finnie, CEO of Egal Pads. 

“This recognition celebrates a product that’s transforming lives with its innovative, accessible design – delivered right where it’s needed, like toilet paper. And we love the fact that it was designed by a man, Tom Devlin, demonstrating how important it is that we all support and understand one another.”

Osteoboost: “Reduce bone loss with a belt”

Another Femtech World award-winner, Osteoboost, also made the list for it’s device which aims to slow bone loss and reduce the risk of fractures in osteoporosis, a condition which disproportionately affects women. The FDA-cleared vibrating belt, which is worn around the hips consistently has been shown in studies to reduce spinal bone loss in by 85 per cent. 

In a statement, Osteoboost CEO, Laura Yecies, said: “This award is more than a milestone for Osteoboost; it’s a moment of acknowledgment that bone health matters, that it deserves focus, and that change is finally coming. 

“We’re proud to be taking a leadership role in a growing movement that’s driving women’s health into a new era. Women’s health is experiencing a golden age of innovation! From menopause and fertility to cardiovascular and skeletal health, scientific researchers and startup founders are tackling long-ignored needs with energy and empathy. Bone health is emerging into that same zeitgeist. And it’s about time.”

Teal Wand: “At-home cervical cancer test”

The Teal Wand, which aims to make cervical screening more comfortable and accessible for women, was also recognised by TIME. Earlier this year the device became the first at-home screening test for cervical cancer to be FDA-approved. 

In a LinkedIn post celebrating the news, the company said: “The Teal Wand was designed to meet women where they are, bringing privacy, comfort, and control to an essential part of preventive care. We’re proud to see women’s health innovation recognised on a global stage and to be part of a movement redefining what it means to design healthcare for women.”

Butterfly iQ3: “A portable solution for rural maternal care”

Approved by the FDA in 2024, Butterfly’s portable ultrasound with 3D imaging was listed in TIME’s Special Mention category. The iQ3 builds on Butterfly’s Ultrasound-on-Chip™ technology to “close critical gaps in healthcare delivery, supporting earlier detection, faster diagnosis and improved patient outcomes.” 

With features such as AI-enhanced processing, 3D imaging modes, and versatile anatomical presets, the technology enables clinicians to bring diagnostic capability to settings with limited infrastructure. TIME notes that Butterfly has received investments from the Gates Foundation to support its use for improving maternal outcomes in sub-Saharan Africa. 

Momcozy Air 1 Ultra-Slim Breast Pump: “A discreet and portable smart pump”

Also given a Special Mention in the parenting category is the Momcozy Air 1 Ultra-Slim Breast Pump, which allows users to track milk volume in real time and control suction strength via a smartphone app. The slim, discreet design also aims to reduce bulk without sacrificing performance or convenience. 

The company’s design philosophy leans on what it describes as “Cosy Tech”, with innovations built around the needs and lived experience of mothers, and feedback from women is crucial for refining usability, comfort, and portability in its products. 

Celebrating innovation in women’s health

To compile the list, TIME solicited nominations from its editors and correspondents around the world, as well as an online application process, paying special attention to growing fields, such as health care and AI. Each contender was evaluated on a number of key factors, including originality, efficacy, ambition, and impact.

For all those on the list representing the femtech sector, it’s welcome recognition, acknowledging the wider importance of innovation in women’s health.

As Joeyband’s Sarah-Almaza Cox put it: “This moment belongs to every woman whose idea has made the world a safer, healthier place.” 

Fertility

Genetic carrier screening before pregnancy: What to know

Published

on

Article produced in association with London Pregnancy Clinic and Jeen Health

For the majority of couples planning a pregnancy, genetic testing is not something they think about until a problem arises.

Pre-conception genetic carrier screening challenges this approach by identifying risk before pregnancy begins.

As panel sizes have grown and at-home testing options have become widely available, carrier screening is transitioning from a niche clinical referral into a mainstream component of reproductive planning.

What Carrier Screening Tests For

Being a carrier of a genetic condition means carrying one copy of a variant in a gene associated with that condition, without being affected by it.

In most cases, carriers are entirely unaware of their status.

The clinical significance of carrier status emerges when both members of a couple carry a variant in the same gene: in this scenario, each pregnancy carries a one in four chance of resulting in a child who inherits two copies of the variant and is affected by the condition.

The conditions most frequently included in expanded carrier screening panels include cystic fibrosis, spinal muscular atrophy (SMA), fragile X syndrome, sickle cell disease, and a range of metabolic and enzyme deficiency disorders.

The Beacon 787 carrier test, offered by Jeen Health, screens for 787 conditions from a single sample, making it one of the most comprehensive panels currently available to UK families.

Who Is Most Likely to Benefit

Any couple planning a pregnancy can consider carrier screening. It is particularly relevant for:

  • Couples with a family history of a known inherited condition
  • Those from populations with higher carrier frequencies for specific conditions, including Ashkenazi Jewish, South Asian and African communities
  • Couples pursuing fertility treatment, where genetic information informs treatment planning
  • Those who wish to have the most complete picture of their reproductive health before conception

Importantly, being a carrier of a condition does not mean a child will be affected. It means there is a defined statistical risk that can be quantified, discussed and planned for with appropriate clinical support.

How the Test Is Performed

Carrier screening is typically carried out on a blood or saliva sample.

For at-home options such as the testing offered by Jeen Health, a cheek swab collection kit is dispatched to the patient, the sample is returned by post, and results are delivered digitally within a defined turnaround period.

In-clinic carrier testing may use a blood draw and provides the advantage of immediate access to a clinical consultation at the point of result delivery.

London Pregnancy Clinic offers genetics counselling through its partnership with Jeen Health, allowing couples to receive and contextualise carrier test results with expert support.

Genetic counselling before and after testing is recommended by Genomics England as a standard component of any genomic testing pathway.

What Happens If Both Partners Are Carriers

If both partners are identified as carriers for the same autosomal recessive condition, they are typically offered further counselling to discuss their options.

These may include proceeding naturally with an awareness of the risk, using prenatal diagnosis (CVS or amniocentesis) during pregnancy to test the fetus, or pursuing preimplantation genetic testing (PGT) in the context of IVF, which allows unaffected embryos to be selected before transfer.

The purpose of identifying carrier status before pregnancy is to give couples time to consider these options without the added pressure of an ongoing pregnancy.

Knowledge of carrier status does not remove reproductive choices; it expands the information available when making them.

The Role of Pre-Conception Services

Carrier screening sits within a broader category of pre-conception care that includes fertility assessments, general health optimisation and, where relevant, management of existing conditions before pregnancy begins.

London Pregnancy Clinic offers pre-conception services encompassing fertility investigations, genetics counselling and carrier testing as part of an integrated 0th trimester approach, allowing couples to address genetic and clinical risk factors before their pregnancy starts rather than after.

Disclaimer: This article is produced for informational purposes only and does not constitute medical advice, diagnosis or treatment.

Clinical guidance referenced reflects published NHS, NICE and RCOG standards as at March 2026. Individual circumstances vary; readers are advised to consult a qualified healthcare professional before acting on any information in this article.

This piece was produced in association with London Pregnancy Clinic and Jeen Health, which provided background clinical information for editorial purposes.

Hyperlinks to external sources are included for reference only and do not represent an endorsement of any product, service or organisation.

Continue Reading

Fertility

Fertility clinic named London finalist in UK StartUp Awards

Published

on

A London-based fertility clinic has been shortlisted for a startup award.

Plan Your Baby was shortlisted as a London finalist for Innovative Startup of the Year at the UK StartUp Awards.

Plan Your Baby is a new generation fertility and pregnancy telehealth clinic that provides fertility treatment and and-to-end pregnancy clinical monitoring and psychological support.

The company said on LinkedIn: “Being recognised in a city as competitive as London is meaningful for our team. 

“The award is judged by industry experts and reflects the growing need for fertility care that is structured, transparent, and centred around the patient.

“Many people come to us looking for clarity in what can often feel like a complex process. 

“Our focus has been to make each step easier to understand and easier to access.”

Plan Your Baby founder Marija Skujina was inspired to launch the company after working at the highest level in private fertility clinics and realising the impact that the traditional approach to fertility treatment was having on clients.

She told Femtech World in a 2023 interview: ““Fertility support is not just a medical procedure, it’s physical, mental, and emotional too.

“That’s why I launched Plan Your Baby: to help parents conceive in a fully supported and holistic manner.”

The UK StartUp Awards aim to ‘recognise the achievements of amazing individuals who have had a great idea, spotted the opportunity and taken the risks to launch a new product or service.’

If selected as the regional winner, Plan Your Baby will go on to the national final at Ideas Fest this September.

Previous winners include Magic AI, makers of a wall-mounted AI fitness mirror that acts as a personal trainer, and EnsiliTech, a medtech startup developing innovative health technology solutions at the intersection of engineering and healthcare.

Continue Reading

News

What 100k+ journalled words reveal about women’s mental load

Published

on

By Katrina Zalcmane, co-founder of Véa

101,000 journalled words. That’s what it took to make women’s mental load measurable – and what it revealed was not what we expected.

We can track a woman’s cycle to the hour, map her hormones, her fertility window, her sleep habits.

But we have had remarkably little structured visibility into the cognitive and emotional load running underneath all of it – the layer that shapes how she makes decisions, takes risks, recovers from pressure and moves through her day.

That’s where the data gets interesting.

Across those 101,000 anonymously journalled words, Véa identified the cognitive signatures of how pressure gets metabolised – not into symptoms, but into patterns.

Overgeneralisation, fortune-telling, catastrophising: the interpretive architecture through which strain quietly becomes self-doubt, avoidance and reduced capacity.

This is not a wellness story – it’s a data story. And it points to a layer of women’s health that has been consistently underinstrumented.

Véa is an neuroscience-backed AI journal that uses semantic embeddings and a state classifier trained on emotional data to read language the way a clinician might – not for keywords but for interpretive patterns.

Each entry is stored as an emotional vector, building a longitudinal map of how a user’s inner state shifts over time.

That is what made this dataset possible.

What the Data Shows

Mental load is often described in domestic terms – the remembering, the planning, the anticipating. But in practice it is also deeply interpretive.

It lives in the ongoing internal work of pre-empting what might go wrong, reading emotional atmospheres, managing self-presentation and correcting internally before anything external has even happened.

That is not just emotional strain. It is a form of continuous cognitive expenditure.

To make that visible, Véa analysed 101,000 anonymously journalled words across 150+ beta testers over 6 months.

These were not a homogenous group: new mothers, neurodivergent women, career-switchers, high performers navigating demanding roles – different lives, different pressures, same underlying patterns.

That breadth matters – it means what we found is not a niche signal. It is structural.

Across that dataset, Véa identified more than 3,000 separate instances of cognitive distortions – recurring interpretive patterns that emerge under pressure.

The five most frequently detected were overgeneralisation, fortune-telling, “should” statements, catastrophising and black-and-white thinking.

On paper these may sound like standard CBT terminology. But taken together they reveal something more significant than stress.

They show that a large part of women’s mental and emotional load is not only what women are carrying externally – it is how rapidly and repeatedly that load gets cognitively organised into threat, failure and self-correction.

What drains women is not just the event. It is the meaning-making around the event.

The Cost of Cognitive Distortions

Overgeneralisation: when one setback becomes a self-story

The most frequent pattern was overgeneralisation: turning one event into a broader conclusion.

One awkward meeting becomes “I’m not good enough”. One rejection becomes “this always happens to me”.

Under stress, the prefrontal cortex loses flexibility, making it harder to hold context and alternative interpretations.

The brain defaults to faster, simplified conclusions, often collapsing a single event into a broader narrative.

For high-performing women, this matters because it directly affects risk-taking and recovery. If one setback becomes a signal of incompetence, the cost of visibility increases.

This aligns with workplace data showing women are more likely to self-deselect from opportunities after negative feedback or perceived underperformance.

Overgeneralisation is not just negative thinking. It is a reduction in cognitive flexibility that limits forward movement.

Fortune-telling: managing problems before they exist

The second pattern was: predicting negative outcomes without evidence, e.g. “It’s going to go badly” or “They’re not going to respond” when you have no facts to back that up.

The brain operates on predictive models, continuously forecasting outcomes.

Under stress, these predictions become threat-biased and less accurate, prioritising avoidance over exploration.

For women, this overlaps with documented anticipatory mental load – the cognitive work of planning, monitoring and pre-empting problems.

The result is inefficiency: energy is spent solving for outcomes that have not occurred.

For high performers, this reduces focus, presence and execution quality because attention is allocated to imagined scenarios rather than current tasks.

“Should” statements: the language of self-surveillance

“Should” statements reflect top-down self-monitoring where behaviour is continuously evaluated against internalised standards. Under sustained pressure, this shifts from regulation to self-criticism, increasing cognitive load.

For women, these standards are often compounded. Performance, emotional regulation and relational behaviour are all being evaluated simultaneously.

Workplace data shows women face higher expectations to balance competence with likability and are more likely to experience competence-based microaggressions.

This creates a loop of self-surveillance, splitting attention between doing and evaluating.

That split is cognitively expensive.

Catastrophising: when the system defaults to threat

Catastrophising reflects rapid escalation to worst-case scenarios.

Under cognitive load, the brain shifts toward amygdala-driven threat processing, reducing the ability to hold ambiguity and increasing urgency-based interpretation.

For high-performing women managing multiple demands, even small uncertainties can trigger escalation because they are processed on top of existing load.

The outcome is distorted prioritisation. Attention is redirected toward perceived threats rather than actual strategic work.

Black-and-white thinking: the rigidity behind perfection

The final major pattern was black-and-white thinking: interpreting situations in binaries, e.g “I’m either doing well or failing”.

It reflects reduced cognitive flexibility, a key function of the prefrontal cortex that allows for nuance and adaptive thinking.

It makes recovery harder and leaves very little room for partial progress, mixed feelings or ordinary human inconsistency.

For high-performing women, this often intersects with perfection pressure. Partial progress is discounted and anything below optimal performance is interpreted as failure.

This creates rigidity. It limits iteration, slows decision-making and makes sustained performance harder, not better.

What This Actually Means

Clinical surveys can tell you a woman is stressed. Journalling treated as longitudinal data tells you something different – it shows you how that stress is being interpreted, repeated and compounded over time.

A survey captures a moment. Language tracked across weeks and months captures a pattern.

That distinction is what makes this dataset structurally different from existing research: it surfaces the cognitive layer that self-report instruments are not designed to reach.

For corporate health and wellbeing

These patterns do not stay at home.

Overgeneralisation after a difficult meeting, fortune-telling before a high-stakes presentation, black-and-white thinking under performance pressure – these are showing up in the workplace every day, invisibly.

For organisations investing in women’s development and retention, this data reframes the conversation.

It is not enough to offer resilience training or mental health days.

The question is whether your wellbeing infrastructure is designed to address the interpretive load that sits underneath performance and whether the interventions you offer are actually built around how women experience that load.

Because that is where capacity is actually being lost.

For clinical and health frameworks

The most widely used depression screener in the world is nine questions long. It captures a snapshot.

What longitudinal language data offers is something clinical instruments have never been designed to provide – continuity.

A running record of how cognitive patterns shift, accumulate and respond to pressure over time, before they become a diagnosis.

That has real implications for how we screen, how we intervene early and how we build a picture of women’s mental health that goes beyond the biological and into the cognitive.

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.